Viewing StudyNCT00417261



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00417261
Status: COMPLETED
Last Update Posted: 2008-06-23
First Post: 2006-12-28

Brief Title: Safety Tolerability Pharmacodynamic and Pharmacokinetic Effects of Single and Multiple-Doses of ATF936 and AXT914 Administered Orally in Healthy Subjects
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Healthy
Keywords:
Name View
Healthy male and female subjects View
ATF936 AXT914 healthy subjects pharmacokinetics parathyroid hormone osteoporosis View